Program Description

Join us for this CME-accredited webinar to explore the clinical performance of gadopiclenol, a new-generation MRI contrast agent. The session begins with an overview of gadopiclenol’s unique chemical properties and a review of current scientific evidence supporting its safety, efficacy, and diagnostic reliability.

Professor Thorsten Bley from the University Medical Center Würzburg in Germany will then share real-world experience and case-based examples from head to toe, highlighting image quality, workflow considerations, and comparisons with other contrast agents. The program concludes with a discussion of the environmental benefits of using half the gadolinium dose while maintaining high signal intensity.

Expand your MRI knowledge and discover how gadopiclenol can enhance diagnostic confidence—register today to participate in this evidence-based, case-driven learning experience.

Learning Objectives

After participating, attendees should be able to:

Incorporate current evidence on the design, safety, and efficacy of gadopiclenol to guide informed MRI contrast agent selection.
Implement optimized MRI protocols that achieve equivalent or greater signal intensity using half the gadolinium dose compared with conventional GBCAs.
Adopt environmentally responsible imaging practices by reducing gadolinium use and understanding its potential impact on wastewater and the environment.

Educational Credits

One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit
One (1) AHRA CRA Credit

Target Audience

Physicians
Technologists
Radiology Administrators
Related Imaging Professionals

Faculty

Dr. Thorsten Bley
Chairman, Diagnostic & Interventional Radiology
University Medical Center

Professor Thorsten Bley is a board-certified radiologist and serves as Chairman of the Department of Diagnostic and Interventional Radiology at the University of Würzburg, Germany. His research training includes scientific collaboration with Dr. Jürgen Hennig, a medical physicist and pioneer in magnetic resonance imaging.

Professor Bley further advanced his expertise in medical physics as a Visiting Professor in the Department of Radiology at the University of Wisconsin–Madison, where he worked closely with Thomas M. Grist, M.D., FACR, Charles Mistretta, Ph.D., and Scott B. Reeder, M.D., Ph.D.

Disclosures

Planner(s)
Dr. Nina Vincoff, as Editor-in-Chief of Applied Radiology discloses no financial relationships with any ineligible companies.

Faculty
Professor Thorsten Bley discloses the following relationships:

Bio Tel Research (KOL Phase III Clinical Trials)
Bracco Diagnostics (Speaker Bureau)
GE Healthcare (Advisory Board)
Guerbet (Speaker, Advisory Board)
Novartis (Advisory Board)
Siemens Healthineers (Research Support)

No individual(s) at the Institute for Advanced Medical Education or Anderson Publishing who had control over the planning or content of this activity has relevant financial relationships with ineligible companies.

Mitigation
Relationships with any ineligible companies were mitigated by a content review by Jason Cox, MD, who has no relevant financial relationships with ineligible companies.

Accreditation Statements

Physicians
In support of improving patient care, this activity has been planned and implemented by the Institute of Advanced Medical Education (IAME) and Applied Radiology. IAME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education to physicians.

IAME designates this internet live activity for a maximum of one (1) AMA/PRA Category CME Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity

Radiologic Technologists
This course meets all criteria and has been approved by the AHRA. The Association for Medical Imaging Management for one (1) ARRT Category A CE Credit.

Radiology Administrators
This course has been approved by the Association for Medical Imaging Management (AHRA) for one (1) CRA in the following domains: (TBD).

Commercial Support

This program is supported through an unrestricted educational grant from Guerbet, LLC.

Clinical Quiz: A 37-year-old male with progressive upper extremity numbness and weakness